Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.
Ressources
Page Web | 2022
l'approvisionnement plus sécuritaire, la politique / le cadre de réglementation, la base de donnés probantes, les résultats
This is a summary of an independent assessment report prepared by Dale McMurchy Consulting based on information gathered through surveys and interviews with safer supply program leads, staff and pa
Webpage | 2022
Safer supply, Policy/Regulatory, Evidence base, Outcomes
This research assessed the impact of COVID-19 on staff working at harm reduction and alcohol and other drug (AOD) services in Australia in the first 9 months of the pandemic.
Original research | 2022
Wrap-around services, Harm reduction
Given the continued expansion of community pharmacy in the continuum of care, it is imperative to characterize alcohol use among pharmacy patients dispensed opioids in order to establish a foundati
Original research | 2022
About pharmacists
Guidelines | 2018
SCS/OPS, Clinical guidance, Harm reduction, Social services, Illegal drugs
Report | 2019
Harm reduction, Injecting drugs, About PWUD
This Evidence Brief asks: What is the evidence of effectiveness of supervised injectable opioid agonist treatment with diacetylmorphine (DAM) or hydromorphone (HDM) on treatment retention (i.e., in
Report | 2017
Evidence base, Safer supply
Formulaire de sélection/d’évaluation | 2022
à propos des personnes qui utilisent des drogues, à propos des prescripteurs, les guides de pratique clinique, le sevrage, l'équité
The Clinical Opiate Withdrawal Scale (COWS) is a validated, clinician-administered instrument initially developed and validated for English-speaking populations.
Original research | 2022
Clinical guidance, Equity, Withdrawal, About prescribers
Social distancing measures and service restrictions posed significant challenges to the health and wellbeing of PWUD.
Original research | 2022
Harm reduction, About PWUD, Policy/Regulatory
Black clients in substance use disorder (SUD) treatment are associated with the lowest successful completion and substance use reductions.
Original research | 2022
Barriers and enablers, About PWUD, Equity, Outcomes, Wrap-around services
Rapport | 2021
la surdose, la mortalité, à propos des personnes qui utilisent des drogues
Report | 2021
Overdose, Mortality, About PWUD
Original research | 2022
Safer supply, Policy/Regulatory, Stimulants, Illegal drugs
To estimate effects of brief substance use interventions delivered in general medical settings.
Lit review | 2022
About prescribers, Illegal drugs, Hospitals, Outcomes
To characterize comparative risks and benefits of methadone versus buprenorphine/naloxone in a contemporary cohort where the unregulated drug supply is dominated by fentanyl.
Original research | 2022
Overdose, Substitution/OAT, About PWUD, Outcomes
This study aims to better understand the impact of legislation aimed to restrict opioid prescribing on patients and providers.
Original research | 2022
Policy/Regulatory, Hesitancy of prescribers , About prescribers
Le présent document d’information offre un aperçu des enjeux émergents ainsi que des défis particuliers que pose la COVID-19 sur le plan de la santé mentale et de l’usage de
Rapport | 2022
la santé mentale, les services de santé numériques, rural / éloigné
